NASDAQ:HTBX - Heat Biologics, Inc.
$1.14
 $0.00
0.00%
4:00PM EDT
2019-04-18
Heat Biologics, Inc. is a development-stage company focused on developing allogeneic, off-the-shelf cellular therapeutic vaccines to combat a range of cancers. The Company is an immuno-oncology company, which focuses on T cell-stimulating platform technologies, such as Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT). Using its ImPACT platform technology, the Company has developed HS-410 (vesigenurtacel-L) as a product candidate to treat non-muscle invasive bladder cancer (NMIBC), and HS-110 (viagenpumatucel-L), which is intended for use in combination with an anti-PD-1 checkpoint inhibitor, as a potential treatment for patients with non-small cell lung cancer (NSCLC). Using its ComPACT platform technology, it has developed HS-120 as a potential treatment for NSCLC. It is conducting a Phase II trial of HS-410 in patients with NMIBC, and a Phase Ib trial of HS-110, in combination with nivolumab (Opdivo) to treat patients with NSCLC. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  HTBX     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 79   203. 85   241. 91  
42 stocks rank:  3. 53 K 1. 44 K 1. 05 K
# analyst opinions:  2. 00   14. 51   13. 97  
mean recommendation:  2. 00   2. 09   2. 01  

quick ratio:  5. 70   5. 27   1. 81  
current ratio:  5. 89   5. 62   2. 25  

target price low:  1. 91   84. 80   115. 21  
target price avg:  0. 75   111. 51   137. 51  
target price high:  0. 90   135. 81   157. 84  
1-yr high:  4. 17   114. 23   138. 78  
last close:  1. 14   87. 66   116. 69  
50-day avg:  1. 30   95. 54   123. 44  
200-day avg:  1. 60   94. 25   121. 11  
1-yr low:  0. 98   72. 78   98. 34  
volume:  163. 93 K 4. 11 M 8. 07 M
50-day avg volume:  625. 16 K 2. 76 M 5. 02 M
200-day avg volume:  388. 29 K 2. 92 M 4. 59 M

1-day return:  0. 00 % -0. 41 % 0. 07 %
this week return:  -1. 72 % -5. 74 % -4. 11 %
12-wk return:  -16. 79 % 1. 61 % -0. 05 %
52-wk return:  2. 70 % 3. 12 % 8. 78 %

enterprise value (EV):  9. 95 M 48. 94 B 114. 64 B
market cap:  38. 84 M 43. 07 B 104. 73 B
EBITDA:  -17. 23 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -0. 58   4. 22   12. 73  
enterprise/revenue (EV/R):  1. 72   63. 17   12. 84  
total revenue:  5. 79 M 10. 62 B 38. 47 B
total debt:  0. 00   12. 24 B 16. 73 B
net income (common):  -15. 73 M 2. 20 B 4. 20 B

shares outstanding:  34. 07 M 571. 70 M 1. 24 B
shares:  31. 52 M 571. 81 M 1. 23 B
shares short:  728. 64 K 10. 17 M 13. 00 M
shares short prior month:  1. 01 M 9. 54 M 17. 33 M
short ratio:  1. 72   5. 41   3. 28  
short % of float:  2. 32 % 5. 45 % 2. 38 %
total cash/share:  0. 84   11. 14   9. 33  
total cash:  27. 72 M 6. 71 B 7. 15 B
free cash flow:  -14. 95 M 3. 58 B 2. 96 B
operating cash flow:  -21. 71 M 4. 15 B 4. 30 B

book value:  0. 93   12. 78   26. 92  
price/book:  1. 22   3. 06   -1. 74  
gross profits:  -10. 44 M 8. 04 B 34. 86 B
operating margins:  -301. 43 % -725. 35 % -89. 04 %
EBITDA margins:  -297. 33 % 10. 94 % 22. 51 %
profit margins:  -271. 56 % 7. 81 % 10. 57 %
gross margins:  -180. 18 % 37. 08 % 55. 70 %

1-yr max volatility:  94. 86 % --- ---
1-yr mean volatility:  0. 47 % 0. 03 % 0. 04 %

1-yr EPS:  -0. 90   2. 40   4. 10  
forward EPS:  -0. 64   3. 97   7. 13  
P/E:  -1. 27   13. 63   22. 72  
forward P/E:  -1. 78   -15. 95   13. 99  
PE/G:  -0. 01   -1. 65   -1. 32  
growth:  235. 40 % 127. 12 % 29. 61 %
earnings high:  -0. 18   1. 00   1. 66  
earnings avg:  -0. 19   0. 77   1. 53  
earnings low:  -0. 21   0. 50   1. 39  
revenue high:  2. 10 M 2. 68 B 10. 78 B
revenue avg:  2. 10 M 2. 59 B 10. 57 B
revenue low:  2. 10 M 2. 49 B 10. 36 B
return on assets:  -37. 67 % -2. 75 % 4. 55 %
return on equity:  -92. 11 % -18. 45 % 5. 46 %
revenue growth:  235. 40 % 92. 86 % 18. 96 %
revenue/share:  0. 33   13. 29   55. 46  

beta (1yr vs S&P500):  0. 71   1. 25   0. 93  
sharpe (1yr):  0. 72   0. 37   0. 70  

held % insiders:  3. 62 % 6. 39 % 3. 38 %
held % institutions:  16. 14 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : HTBX
.    + 0.168 =         0.168 :: INITIAL WEIGHT
.   + 31.105 =        31.273 :: spline projection addition
.    x 1.431 =        44.765 :: industry recommendation factor
.    x 2.098 =        93.925 :: symbol recommendation factor
.    x 1.027 =        96.479 :: EV/R factor
.    x 0.996 =        96.115 :: return on assets factor
.    x 0.991 =         95.23 :: return on equity factor
.    x 2.458 =       234.086 :: revenue growth factor
.    x 2.952 =       691.072 :: current ratio factor
.    x 1.101 =       761.104 :: quick ratio factor
.    x 1.258 =       957.116 :: short ratio factor
.    x 2.012 =      1925.938 :: price-to-book factor
.    x 2.156 =      4152.053 :: P/E weight
.    x 2.209 =      9171.716 :: PE/G factor
.    x 1.513 =     13879.161 :: beta factor
.    x 0.716 =      9939.152 :: sharpe factor
.    x 1.897 =     18856.213 :: target low factor
.    x 0.896 =     16901.382 :: target mean factor
.    x 0.954 =     16125.893 :: target high factor
.     x 1.31 =     21123.112 :: industry 2-weeks return factor
.    x 0.948 =      20026.77 :: "drift" penalty 2 days ago
.    x 0.987 =     19770.194 :: overall "drift" factor
.    x 0.998 =     19726.547 :: largest single-day jump factor
.    x 0.062 =      1229.835 :: low price factor
.      x 1.0 =      1229.635 :: factor hist industry gain for week 16
.   cubeRoot =        10.713 :: reduced to standardize
.    - 22.79 =         0.792 :: add/subtract for performance
.                      0.792 :: FINAL WEIGHT for NASDAQ:HTBX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org